1例老年子宫内膜透明细胞癌化学治疗后腹腔引流液异常的临床分析  

A Case Analysis of Peritoneal Drainage Anomalies After Chemotherapy in an Elderly Patients with Endometrial Hyaline Cell Carcinoma

作　　者：高羽 吴越[2] GAO Yu;WU Yue(Chengdu Women's and Children's Central Hospital,Chengdu,Sichuan,China 610000;Sichuan Provincial People's Hospital,Chengdu,Sichuan,China 610000)

机构地区：[1]四川省成都市妇女儿童中心医院,四川成都610000 [2]四川省人民医院,四川成都610000

出　　处：《中国药业》2019年第11期108-110,共3页China Pharmaceuticals

摘　　要：目的探讨子宫内膜透明细胞癌化学治疗(简称化疗)后腹腔引流液异常变化的原因。方法从感染、疾病本身、基础疾病、药物因素方面分析引起子宫内膜透明细胞癌化疗后腹腔引流液异常变化的原因。结果老年子宫内膜透明细胞癌化疗后腹腔引流液异常增多的原因为生长抑素导致的反跳现象。结论生长抑素反跳引起子宫内膜透明细胞癌化疗后腹腔引流液异常,需掌握停药指征及停药方式。Objective To investigate the cause of abnormal changes in peritoneal drainage after chemotherapy in a patient with endometrial hyaline cell carcinoma.Methods The cause of abnormal changes in peritoneal drainage after chemotherapy in the patient with endometrial hyaline cell carcinoma was analyzed from the aspects of infection,disease itself,basic disease and drug factors.Results The abnormal increase of peritoneal drainage after chemotherapy in the patient with endometrial hyaline cell carcinoma was caused by the rebound phenomenon of somatostatin.Conclusion Somatostatin rebound can cause abnormal peritoneal drainage after chemotherapy in the patient with endometrial hyaline cell carcinoma.It is necessary to master the indication and mode of stopping the medicine.

关 键 词：透明细胞癌 腹腔引流液 生长抑素 反跳现象 化学治疗 合理用药 

分 类 号：R969.3[医药卫生—药理学] R979.1[医药卫生—药学]